Cargando…

Plasma ACE2 species are differentially altered in COVID‐19 patients

Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID‐19 disease, caused by severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) virus. Here, we examine the levels of various plasma species of the SARS‐CoV‐2 host receptor, the angiotensin‐converting enz...

Descripción completa

Detalles Bibliográficos
Autores principales:	García‐Ayllón, María‐Salud, Moreno‐Pérez, Oscar, García‐Arriaza, Juan, Ramos‐Rincón, José‐Manuel, Cortés‐Gómez, María‐Ángeles, Brinkmalm, Gunnar, Andrés, Mariano, León‐Ramírez, José‐Manuel, Boix, Vicente, Gil, Joan, Zetterberg, Henrik, Esteban, Mariano, Merino, Esperanza, Sáez‐Valero, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441911/ https://www.ncbi.nlm.nih.gov/pubmed/34191346 http://dx.doi.org/10.1096/fj.202100051R

Ejemplares similares

Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes
por: Lennol, Matthew P., et al.
Publicado: (2023)

Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy
por: Lennol, Matthew P., et al.
Publicado: (2022)

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2017)

CSF Presenilin-1 complexes are increased in Alzheimer’s disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2013)

Presenilin 1 Modulates Acetylcholinesterase Trafficking and Maturation
por: Cortés-Gómez, María-Ángeles, et al.
Publicado: (2023)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2018)

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
por: Monge-García, Sonia, et al.
Publicado: (2023)

Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
por: Moreno-Pérez, Oscar, et al.
Publicado: (2020)

Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression
por: Cortés‐Gómez, María‐Ángeles, et al.
Publicado: (2020)

Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients
por: Moreno-Pérez, Oscar, et al.
Publicado: (2020)

Inhibition of γ-Secretase Leads to an Increase in Presenilin-1
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2017)

Revisiting the Role of Acetylcholinesterase in Alzheimer’s Disease: Cross-Talk with P-tau and β-Amyloid
por: García-Ayllón, María-Salud, et al.
Publicado: (2011)

Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase
por: Campanari, Maria-Letizia, et al.
Publicado: (2016)

Readthrough Acetylcholinesterase Is Increased in Human Liver Cirrhosis
por: García-Ayllón, María-Salud, et al.
Publicado: (2012)

Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease
por: Monge-García, Victoria, et al.
Publicado: (2021)

Heteromers of amyloid precursor protein in cerebrospinal fluid
por: Cuchillo-Ibañez, Inmaculada, et al.
Publicado: (2015)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
por: García-Arriaza, Juan, et al.
Publicado: (2021)

Fatality and risk features for prognosis in COVID-19 according to the care approach – a retrospective cohort study
por: Andrés, Mariano, et al.
Publicado: (2021)

Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
por: Lopez-Font, Inmaculada, et al.
Publicado: (2015)

Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer’s disease
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2016)

Bacteraemia and quick Sepsis Related Organ Failure Assessment (qSOFA) are independent risk factors for long-term mortality in very elderly patients with suspected infection: retrospective cohort study
por: Hernández-Quiles, Rubén, et al.
Publicado: (2022)

Altered Levels of Acetylcholinesterase in Alzheimer Plasma
por: García-Ayllón, María-Salud, et al.
Publicado: (2010)

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
por: Sjödin, Simon, et al.
Publicado: (2016)

Hospitalized patients with breakthrough COVID-19: Clinical features and poor outcome predictors
por: Moreno-Perez, Oscar, et al.
Publicado: (2022)

Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
por: Nájera, José Luis, et al.
Publicado: (2010)

Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
por: García-Arriaza, Juan, et al.
Publicado: (2010)

Post-COVID syndrome. The never ending challenge()
por: Boix, Vicente, et al.
Publicado: (2022)

Síndrome post-COVID. El desafío continúa
por: Boix, Vicente, et al.
Publicado: (2022)

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
por: Sjödin, Simon, et al.
Publicado: (2017)

Association between Clinical Frailty Scale (CFS) and clinical presentation and outcomes in older inpatients with COVID-19
por: Martí-Pastor, Ana, et al.
Publicado: (2023)

The quick Sepsis-related Organ Failure Assessment (qSOFA) is a good predictor of in-hospital mortality in very elderly patients with bloodstream infections: A retrospective observational study
por: Ramos-Rincón, José M., et al.
Publicado: (2019)

Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
por: Moreno-Pérez, Oscar, et al.
Publicado: (2021)

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
por: Agüero, Pablo, et al.
Publicado: (2020)

Current situation in the development of a preventive HIV vaccine
por: Alcamí, José, et al.
Publicado: (2005)

Situación actual en el desarrollo de una vacuna preventiva frente al VIH
por: Alcamí, José, et al.
Publicado: (2005)

Brain cholinergic impairment in liver failure
por: García-Ayllón, María-Salud, et al.
Publicado: (2008)

A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status
por: Ramos-Rincón, José Manuel, et al.
Publicado: (2023)

Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
por: Q. Marín, María, et al.
Publicado: (2018)

Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways
por: García-Arriaza, Juan, et al.
Publicado: (2013)

Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein
por: Lorente, Elena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9m4vk8pohiot83lpck78gkj678